by Administrators Qynapse | Aug 26, 2021 | News
BOSTON, MA, July 26, 2021 /PRNewswire/ – QYNAPSE Inc., a medical technology company commercializing an AI-powered and proprietary neuroimaging software platform, is attending the Alzheimer’s Association International Conference 2021 (AAIC) on July 26-30, 2021 in...
by Administrators Qynapse | Jun 15, 2021 | News
BOSTON, MA, May 30, 2021 /PRNewswire/ – QYNAPSE Inc., a medical technology company commercializing the most advanced artificial intelligence neuroimaging platform, today announced it will present clinical data on QyScore® for Alzheimer’s disease and multiple sclerosis...
by Administrators Qynapse | May 30, 2021 | News
BOSTON, MA, May 30, 2021 – QYNAPSE Inc., an AI neuroimaging medical technology company, joins the global multiple sclerosis (MS) community in recognition of World MS Day to raise awareness for everyone affected by MS. Emphasizing the World MS Day 2021 theme, MS...
by Administrators Qynapse | Apr 26, 2021 | News
BOSTON, MA, April 26, 2021 – QYNAPSE Inc., a medical technology company commercializing the most advanced artificial intelligence neuroimaging platform, is pleased to participate in the Sachs 4th Annual Neuroscience Innovation Forum (#Sachs_NIF) on April 28-30, 2021,...
by Administrators Qynapse | Dec 30, 2020 | News
New Global Industry Coalition That Aims to Dramatically Increase Access for All Patients Populations in Clinical Trials and Research Paris, France and Boston, MA, December 30, 2020 – QYNAPSE Inc. joins a historic alliance of fifty life sciences and healthcare...